Janus Pharmaceuticals Raises Series A Funding of More Than $2 Million

Janus Pharmaceuticals Inc. (Janus) announced the closing of the company's Series A financing round for a total of over $2 million. Lead investor was Private Equity Japan Co., Ltd (PEJ). of Tokyo, Japan. Commensurate with this funding, Mr. Shinji Kimura Managing Director, PEJ, joins the Janus Board of Directors. Janus currently has three products in development, JA-001, a topical formulation of a widely studied antiviral product for the treatment of shingles (herpes zoster); JA-002, a gel formulation of a novel proprietary antibiotic targeting prevention and treatment of bacterial infections of the skin; and JA-003, an antibiotic cream for the treatment of acne.

Yahoo News (http://biz.yahoo.com/bw/050412/125077.html?.v=1)